Trade Diasorin SPA - DIAm CFD

Add to favourite

90.55

0.96%

0.34

Low: 88.33

High: 90.88

Market Trading Hours* (UTC) Open now
Closes on Friday at 15:30

Mon - Fri: 07:00 - 15:30

Summary
Historical Data
Events
Income Statement
Balance Sheet
Cash Flow

Trading сonditions

Spread

0.34

Long position overnight fee

-0.022102%

Short position overnight fee

-0.000121%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

EUR

Margin

Stock exchange

Italy

Commission on trade

*Information provided by Capital.com

DiaSorin SpA ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats

Prev. Close*	89.59
Open*	89.37
1-Year Change*	-8.02%
Day's Range*	88.33 - 90.88
52 wk Range	81.24-130.00
Average Volume (10 days)	150.17K
Average Volume (3 months)	3.98M
Market Cap	4.79B
P/E Ratio	-100.00K
Shares Outstanding	53.29M
Revenue	-100.00B
EPS	-100.00K
Dividend (Yield %)	1.28595
Beta	-0.12
Next Earnings Date	Mar 4, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 18, 2024	89.59	-0.82	-0.91%	90.41	91.36	88.93
Apr 17, 2024	90.39	1.36	1.53%	89.03	91.04	88.67
Apr 16, 2024	87.09	0.52	0.60%	86.57	87.39	86.33
Apr 15, 2024	87.41	1.06	1.23%	86.35	88.31	86.27
Apr 12, 2024	86.37	-1.52	-1.73%	87.89	88.15	85.93
Apr 11, 2024	87.55	1.48	1.72%	86.07	88.51	86.05
Apr 10, 2024	86.51	-2.24	-2.52%	88.75	89.37	86.15
Apr 9, 2024	88.55	3.44	4.04%	85.11	88.89	85.11
Apr 8, 2024	85.61	0.76	0.90%	84.85	85.89	84.23
Apr 5, 2024	83.17	0.36	0.43%	82.81	84.13	82.47
Apr 4, 2024	83.79	-1.14	-1.34%	84.93	85.17	83.59
Apr 3, 2024	85.49	-0.36	-0.42%	85.85	86.23	85.35
Apr 2, 2024	86.05	-2.68	-3.02%	88.73	88.99	86.03
Mar 28, 2024	89.35	0.80	0.90%	88.55	90.15	87.47
Mar 27, 2024	88.63	1.08	1.23%	87.55	88.69	87.13
Mar 26, 2024	87.01	-0.44	-0.50%	87.45	87.47	86.37
Mar 25, 2024	87.47	-0.50	-0.57%	87.97	88.37	86.49
Mar 22, 2024	88.05	-0.36	-0.41%	88.41	88.89	87.43
Mar 21, 2024	88.85	-2.47	-2.70%	91.32	91.66	88.85
Mar 20, 2024	91.62	-2.52	-2.68%	94.14	94.38	90.84

Diasorin SPA Events

Time (UTC)	Country	Event
Wednesday, April 24, 2024
Time (UTC) 12:30	Country IT	Event DiaSorin SpA Annual Shareholders Meeting DiaSorin SpA Annual Shareholders Meeting Forecast - Previous -
Friday, April 26, 2024
Time (UTC) 10:00	Country IT	Event DiaSorin SpA Annual Shareholders Meeting DiaSorin SpA Annual Shareholders Meeting Forecast - Previous -
Monday, May 20, 2024
Time (UTC) 12:00	Country IT	Event DiaSorin SpA DiaSorin SpA Forecast - Previous -

View all events

Annual
Quarterly

	2022	2021	2020	2019	2018
Total revenue	1361.14	1237.65	881.305	706.319	669.197
Revenue	1361.14	1237.65	881.305	706.319	669.197
Cost of Revenue, Total	460.525	412.883	278.4	217.628	213.428
Gross Profit	900.613	824.771	602.905	488.691	455.769
Total Operating Expense	1009.88	818.155	557.079	488.458	464.672
Selling/General/Admin. Expenses, Total	421.493	310.147	219.027	214.42	202.135
Research & Development	78.702	57.485	43.117	41.752	39.631
Depreciation / Amortization	18.202	12.606	7.683	6.196	5.451
Interest Expense (Income) - Net Operating				-0.012	1.187
Unusual Expense (Income)	24.062	21.902	5.885	4.615	4.139
Other Operating Expenses, Total	6.894	3.132	2.967	3.859	-1.299
Operating Income	351.26	419.499	324.226	217.861	204.525
Interest Income (Expense), Net Non-Operating	-24.426	-19.056	-1.93	-0.532	0.706
Other, Net	-0.894	-1.108	-0.923	-1.042	-0.866
Net Income Before Taxes	325.94	399.335	321.373	216.287	204.365
Net Income After Taxes	240.11	310.732	248.296	175.735	158.13
Minority Interest	0.797	0.236	-0.425	0	-0.002
Net Income Before Extra. Items	240.907	310.968	247.871	175.735	158.128
Net Income	240.907	310.968	247.871	175.735	158.128
Income Available to Common Excl. Extra. Items	240.907	310.968	247.871	175.735	158.128
Income Available to Common Incl. Extra. Items	240.907	310.968	247.871	175.735	158.128
Diluted Net Income	240.907	310.968	247.871	175.735	158.128
Diluted Weighted Average Shares	55.9483	57.5867	55.0824	54.9172	55.5131
Diluted EPS Excluding Extraordinary Items	4.30589	5.4	4.5	3.2	2.84848
Dividends per Share - Common Stock Primary Issue	1.1	1.05	1	0.95	0.9
Diluted Normalized EPS	4.62271	5.69594	4.58255	3.26828	2.90617

	Jun 2023	Dec 2022	Jun 2022	Dec 2021	Jun 2021
Total revenue	576.39	675.7	685.438	722.238	515.416
Revenue	576.39	675.7	685.438	722.238	515.416
Cost of Revenue, Total	197.705	224.629	235.896	252.802	160.081
Gross Profit	378.685	451.071	449.542	469.436	355.335
Total Operating Expense	458.994	521.114	488.764	504.598	313.557
Selling/General/Admin. Expenses, Total	202.117	221.952	199.541	195.422	114.725
Research & Development	35.612	41.205	37.497	38.052	19.433
Depreciation / Amortization	10.743	9.411	8.791	8.535	4.071
Interest Expense (Income) - Net Operating				-0.444	0.444
Unusual Expense (Income)	8.388	20.181	3.881	9.016	12.886
Other Operating Expenses, Total	4.429	3.736	3.158	1.215	1.917
Operating Income	117.396	154.586	196.674	217.64	201.859
Interest Income (Expense), Net Non-Operating	-10.345	-11.497	-15.189	-13.831	-5.225
Other, Net	5.753	1.071	0.295	-0.584	-0.524
Net Income Before Taxes	112.804	144.16	181.78	203.225	196.11
Net Income After Taxes	86.859	99.303	140.807	160.708	150.024
Minority Interest	1.259	0.089	0.708	0.142	0.094
Net Income Before Extra. Items	88.118	99.392	141.515	160.85	150.118
Net Income	88.118	99.392	141.515	160.85	150.118
Income Available to Common Excl. Extra. Items	88.118	99.392	141.515	160.85	150.118
Income Available to Common Incl. Extra. Items	88.118	99.392	141.515	160.85	150.118
Dilution Adjustment					-1.34133
Diluted Net Income	88.118	99.392	141.515	160.85	148.777
Diluted Weighted Average Shares	55.8802	55.9483	54.6653	57.6569	57.0026
Diluted EPS Excluding Extraordinary Items	1.57691	1.7765	2.58875	2.78978	2.61
Dividends per Share - Common Stock Primary Issue	0	1.1	0	1.05	0
Diluted Normalized EPS	1.69249	2.02497	2.64375	2.91344	2.78294

Annual
Quarterly

	2022	2021	2020	2019	2018
Total Current Assets	1028.94	958.291	713.917	530.761	414.86
Cash and Short Term Investments	413.218	403.02	340.007	202.14	96.525
Cash & Equivalents	241.776	403.02	339.881	157.552	73.103
Short Term Investments	171.442	0	0.126	44.588	23.422
Total Receivables, Net	220.035	217.588	165.678	132.513	131.092
Accounts Receivable - Trade, Net	220.035	217.588	165.678	132.513	131.092
Total Inventory	306.503	298.049	191.234	171.127	160.396
Prepaid Expenses					3.86
Other Current Assets, Total	89.184	39.634	16.998	24.981	22.987
Total Assets	3408.08	3231.15	1246.45	1063.55	905.94
Property/Plant/Equipment, Total - Net	268.448	276.197	140.497	128.385	94.981
Property/Plant/Equipment, Total - Gross	555.268	524.315	347.885	330.774	281.657
Accumulated Depreciation, Total	-286.822	-248.119	-207.386	-202.389	-186.676
Goodwill, Net	826.352	789.631	154.774	164.681	162.616
Intangibles, Net	1168.71	1153.74	201.963	205.598	210.468
Long Term Investments	32.182	10.742	0.026	0.027	0.027
Other Long Term Assets, Total	83.449	42.553	35.269	34.1	22.988
Total Current Liabilities	341.314	298.229	160.213	122.479	138.452
Accounts Payable	104.204	84.773	65.485	55.733	57.286
Notes Payable/Short Term Debt	0	0	0	0	0
Current Port. of LT Debt/Capital Leases	120.02	104.882	4.209	4.812	20.601
Other Current Liabilities, Total	49.412	43.244	42.845	20.773	25.24
Total Liabilities	1889.09	1864.78	291.768	214.929	201.207
Total Long Term Debt	1231.96	1294.75	30.451	24.466	0.081
Long Term Debt	1170.96	1228.27
Deferred Income Tax	229.31	185.337	10.066	7.135	5.05
Minority Interest	0.761	1.562	1.641	0	0.002
Other Liabilities, Total	85.743	84.9	89.397	60.849	57.622
Total Equity	1518.99	1366.38	954.678	848.623	704.733
Common Stock	55.948	55.948	55.948	55.948	55.948
Additional Paid-In Capital	18.155	18.155	18.155	18.155	18.155
Retained Earnings (Accumulated Deficit)	1323.89	1246.07	907.562	752.909	617.158
Treasury Stock - Common	-281.277	-120.022	-109.546	-81.849	-87.784
Other Equity, Total	402.277	166.23	82.559	103.46	101.256
Total Liabilities & Shareholders’ Equity	3408.08	3231.15	1246.45	1063.55	905.94
Total Common Shares Outstanding	53.5129	54.7463	54.7221	54.7907	54.6572
Capital Lease Obligations	61.004	66.478	30.451	24.466	0.081
Accrued Expenses	67.678	65.33	47.674	41.161	35.325

	Jun 2023	Dec 2022	Jun 2022	Dec 2021	Jun 2021
Total Current Assets	912.573	1028.94	979.252	958.291	1289.29
Cash and Short Term Investments	312.458	413.218	397.089	403.02	905.426
Cash & Equivalents	256.287	241.776	382.441	403.02	896.842
Short Term Investments	56.171	171.442	14.648	0	8.584
Total Receivables, Net	186.103	220.035	242.803	217.588	158.426
Accounts Receivable - Trade, Net	186.103	220.035	201.225	217.588	158.426
Total Inventory	322.519	306.503	313.392	298.049	202.986
Prepaid Expenses			18.621		9.452
Other Current Assets, Total	91.493	89.184	7.347	39.634	13.004
Total Assets	3204.56	3408.08	3438.05	3231.15	1859.27
Property/Plant/Equipment, Total - Net	262.351	268.448	289.873	276.197	159.739
Goodwill, Net	812.142	826.352	855.991	789.631	158.134
Intangibles, Net	1144.21	1168.71	1236.88	1153.74	214.254
Long Term Investments	24.572	32.182	31.273	10.742	0.026
Other Long Term Assets, Total	48.711	83.449	44.789	42.553	37.819
Total Current Liabilities	282.686	341.314	233.679	298.229	154.56
Accounts Payable	106.766	104.204	75.494	84.773	79.248
Notes Payable/Short Term Debt	0	0	0	0	0
Current Port. of LT Debt/Capital Leases	64.978	120.02	59.076	104.882	5.361
Other Current Liabilities, Total	60.891	49.412	20.917	108.574	69.951
Total Liabilities	1708.42	1889.09	1893.41	1864.78	723.82
Total Long Term Debt	1132.88	1231.96	1372.14	1294.75	463.738
Capital Lease Obligations	63.432	61.004	66.853	66.478	463.738
Deferred Income Tax	220.86	229.31	200.108	185.337	10.703
Minority Interest	-0.485	0.761	0.894	1.562	1.547
Other Liabilities, Total	72.481	85.743	86.594	84.9	93.272
Total Equity	1496.14	1518.99	1544.64	1366.38	1135.45
Common Stock	55.948	55.948	55.948	55.948	55.948
Additional Paid-In Capital	18.155	18.155	18.155	18.155	18.155
Retained Earnings (Accumulated Deficit)	1327.91	1323.89	1305.01	1246.07	1070
Treasury Stock - Common	-302.625	-281.277	-185.693	-120.022	-114.062
Other Equity, Total	396.755	402.277	351.221	166.23	105.404
Total Liabilities & Shareholders’ Equity	3204.56	3408.08	3438.05	3231.15	1859.27
Total Common Shares Outstanding	53.2891	53.5129	54.2039	54.7463	54.7187
Long Term Debt	1069.45	1170.96	1305.29	1228.27
Accrued Expenses	50.051	67.678	78.192

Annual
Quarterly

	2022	2021	2020	2019	2018
Net income/Starting Line	240.11	310.732	248.296	175.735	158.13
Cash From Operating Activities	389.341	400.664	304.562	232.67	209.879
Cash From Operating Activities	153.267	95.993	61.034	58.972	50.826
Non-Cash Items	47.851	42.634	11.228	6.82	-0.884
Cash Taxes Paid	91.562	118.096	36.891	42.612	25.763
Changes in Working Capital	-51.887	-48.695	-15.996	-8.857	1.807
Cash From Investing Activities	-231.952	-1611.19	-73.023	-59.126	-71.428
Capital Expenditures	-113.686	-117.373	-74.825	-55.79	-52.787
Other Investing Cash Flow Items, Total	-118.266	-1493.82	1.802	-3.336	-18.641
Cash From Financing Activities	-333.043	1256.49	-40.889	-89.482	-224.202
Financing Cash Flow Items		-0.001	44.788	-20.666	-9.448
Total Cash Dividends Paid	-57.052	-54.709	-52.053	-49.231	-145.268
Issuance (Retirement) of Stock, Net	-159.849	-8.578	-26.093	7.016	-65.296
Issuance (Retirement) of Debt, Net	-116.142	1319.77	-7.531	-26.601	-4.19
Foreign Exchange Effects	14.41	17.182	-8.321	0.387	-0.486
Net Change in Cash	-161.244	63.139	182.329	84.449	-86.237

	Dec 2022	Jun 2022	Dec 2021	Jun 2021
Net income/Starting Line	240.11	140.808	310.732	150.024
Cash From Operating Activities	389.341	180.106	400.664	173.67
Cash From Operating Activities	153.267	66.889	95.993	29.475
Non-Cash Items	47.851	-3.326	42.634	26.661
Cash Taxes Paid	91.562	58.477	118.096	66.081
Changes in Working Capital	-51.887	-24.265	-48.695	-32.49
Cash From Investing Activities	-231.952	-51.894	-1611.19	-49.605
Capital Expenditures	-113.686	-55.494	-117.373	-50.806
Other Investing Cash Flow Items, Total	-118.266	3.6	-1493.82	1.201
Cash From Financing Activities	-333.043	-175.141	1256.49	429.266
Financing Cash Flow Items		-0.001	-0.001	0
Total Cash Dividends Paid	-57.052	-55.717	-54.709	-54.012
Issuance (Retirement) of Stock, Net	-159.849	-65.173	-8.578	-3.839
Issuance (Retirement) of Debt, Net	-116.142	-54.25	1319.77	487.117
Foreign Exchange Effects	14.41	26.35	17.182	3.63
Net Change in Cash	-161.244	-20.579	63.139	556.961

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

1:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Diasorin Company profile

DiaSorin SpA is an Italian multinational group, specialising in vitro diagnostics. The company develops, produces, and commercialises reagent kits for hospital and private testing laboratories. Additionally, the company serves the immuno- and molecular- diagnostics markets. Founded in 1968, DiaSorin is headquartered in Saluggia, Italy. The biotechnology powerhouse boasts direct and indirect global commercial presence across all continents. The group's business operations are divided into the following segments: the Immunodiagnostics market and the Molecular Diagnostics market. The former provides cutting-edge immunodiagnostics solutions, based on Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA) techniques. The latter offers molecular diagnostics services for infectious diseases and Leukaemia. DiaSorin trades on the Milan Stock Exchange (MTA) under the ticker DIA and is featured in the FTSE Italia Mid Cap Index. Capital.com enables you to browse the DiaSorin share price (DIA) chart in real time and find more investment opportunities within the biotechnology sector.

Industry:

Laboratory Diagnostic & Testing Substances

Via Crescentino Snc
SALUGGIA
VERCELLI 13040
IT

Income Statement

Annual
Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024